| AULGX | VIGAX | AULGX / VIGAX | |
| Total Expense Ratio | 0.67 | 0.05 | 1,340% |
| Annual Report Gross Expense Ratio | 0.72 | 0.05 | 1,440% |
| Fund Existence | 9 years | 25 years | - |
| Gain YTD | 11.963 | 16.783 | 71% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 27B | 357B | 8% |
| Annual Yield % from dividends | 0.00 | 0.40 | - |
| Returns for 1 year | 10.94 | 19.95 | 55% |
| Returns for 3 years | 67.35 | 111.81 | 60% |
| Returns for 5 years | 46.48 | 100.53 | 46% |
| Returns for 10 years | N/A | 337.63 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 31.90 | 0.36 | +1.14% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| PMBS | 49.57 | 0.03 | +0.06% |
| PIMCO Mortgage-Backed Securities Act ETF | |||
| AOHY | 11.05 | 0.01 | +0.05% |
| Angel Oak High Yield Opportunities ETF | |||
| MYD | 10.48 | -0.05 | -0.47% |
| Blackrock Muniyield Fund | |||
| DSI | 124.54 | -1.29 | -1.03% |
| iShares ESG MSCI KLD 400 ETF | |||